![Nicholas Edward John West](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicholas Edward John West
Directeur Technique/Scientifique/R&D chez SHOCKWAVE MEDICAL
Profil
Nicholas Edward John West has held positions as Director & Chief Medical Officer at PlaqueTec Ltd.
and Chief Medical Officer at Shockwave Medical, Inc.
Postes actifs de Nicholas Edward John West
Sociétés | Poste | Début |
---|---|---|
SHOCKWAVE MEDICAL | Directeur Technique/Scientifique/R&D | - |
PlaqueTec Ltd.
![]() PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
PlaqueTec Ltd.
![]() PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Shockwave Medical, Inc.
![]() Shockwave Medical, Inc. Medical SpecialtiesHealth Technology Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA. | Health Technology |